Research Options:

Week of Expected Pricing 10/22/2021
Company Name XILIO THERAPEUTICS INC
Proposed Ticker XLO
CUSIP 98422T100
Business Description A biotechnology company focused on harnessing the immune system to, achieve deep and durable clinical responses to improve the lives of patients, with cancer. We have built our geographically precise solutions, or GPS,, platform to rapidly engineer novel molecules, including cytokines and other, biologics, that are designed to optimize their therapeutic index by, geographically localizing their activity inside tumors.
Lead Underwriter Cowen and Company, LLC, Guggenheim Securities, LLC, Morgan Stanley & Co. LLC
Co-Managers Raymond James and Associates, Inc.
Initial Shares 73,53,000
Revised Initial Shares N/A
Initial Price $16.00-$18.00
Revised Price N/A
Final Price $16.00
Final Ticker XLO

 

 

   
  © 2024 ICE Data Services. All rights reserved.